DOJ is backing AbbVie in its battle to overturn a Colorado law that prohibits pharmaceutical companies from placing ...
Scoop: Cigna has acquired CarepathRx, a large pharmacy backed by private equity that dispenses prescription drugs to nearly ...
They ran through a menu of takes on biotech stock performance, M&A, Food and Drug Administration turmoil, election intrigue, ...
The Trump administration issued a nationwide moratorium on new suppliers for certain medical equipment, citing fraud.
The order aims to shore up production of the herbicide glyphosate (better known as the active ingredient in the weed killer ...
“Yuge” news. There’s now a MAHA pill, though the seller took some liberties with the acronym. Send news tips and male-enhancement suggestions to John.Wilkerson@statnews.com or John_Wilkerson.07 on ...
Today, a story about the regulatory challenges behind the Neuralink hype.
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...
In his State of the Union address, President Trump claimed he had brought U.S. prescription drug costs from the highest in the world to the lowest ...
The FDA’s recent rejection of a rare disease cell therapy — despite prior internal support and an approval in Europe — is prompting questions about whether the agency’s rhetoric matches its regulatory ...
An experimental therapy for a rare blood cancer was rejected by the FDA though internal reviewers had recommended it be cleared ...
Paul Offit, a renowned vaccine inventor and former CDC adviser, has been asked three times to debate health secretary Robert F. Kennedy Jr., he said yesterday at a webinar hosted by MedPage Today.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果